Heart Failure Clinic, Cardiology Service, Germans Trias i Pujol Hospital, Carretera del Canyet s/n, Barcelona, 08916, Spain.
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
ESC Heart Fail. 2021 Dec;8(6):4506-4516. doi: 10.1002/ehf2.13660. Epub 2021 Nov 1.
In ambulatory patients with chronic heart failure (HF), congestion and decongestion assessment may be challenging. The aim of this study is to assess the value of lung ultrasound (LUS) in outpatients with HF in characterizing decompensation and recompensation, and in outcomes prediction.
Heart failure outpatients attended to establish HF decompensation were included. LUS was blindly performed at baseline (LUS1) and at clinical recompensation (LUS2). B-lines were counted in eight scanned areas. Diagnosis of no HF decompensation vs. right-sided, left-sided, or global HF decompensation, and patients' management were performed by physicians blinded to LUS1. Outcome was the composite of all-cause death or HF-related hospitalization. Two hundred and thirty-three suspicions of HF decompensation were included in 187 patients (71.4 ± 11.3 years, 66.8% men). Mean B-line (LUS1) was 17.6 ± 11.2 vs. 3.7 ± 4.5 for episodes with and without HF decompensation, respectively (P < 0.001). Global HF decompensation showed the highest number of B-lines (20.6 ± 11), followed by left-sided (19.7 ± 11.6) and right-sided (13.5 ± 9.8). B-lines declined to 6.9 ± 6.7 (LUS2) (P < 0.001 vs. LUS1) after treatment, within a mean time of 24.2 ± 23.7 days [median 13.5 days (interquartile range 6-40)]. B-lines were significantly associated with the composite endpoint at 30 days (hazard ratio [HR] 1.04 [95% confidence interval 1.01-1.07], P = 0.02), but not at 60 (P = 0.22) or 180 days (P = 0.54). In multivariable analysis, B-line number remained as an independent predictor of the composite endpoint at 30 days, [HR 1.04 (1.01-1.07), P = 0.014], with a 4% increase risk per B-line added. B-lines correlated significantly with CA125 (R = 0.30, P = 0.001).
Lung ultrasound supports the diagnostic work-up of congestion and decongestion in chronic HF outpatients and identifies patients at high risk of short-term events.
在慢性心力衰竭(HF)的门诊患者中,充血和去充血的评估可能具有挑战性。本研究旨在评估肺部超声(LUS)在 HF 门诊患者中的价值,以确定其在心力衰竭失代偿和再代偿中的特征,并预测结局。
纳入了因 HF 失代偿而就诊的 HF 门诊患者。在基线(LUS1)和临床再代偿时(LUS2)进行盲法 LUS 检查。在 8 个扫描区域计数 B 线。由不了解 LUS1 的医生对无 HF 失代偿与右侧、左侧或全心 HF 失代偿的诊断以及患者管理进行判断。结局是全因死亡或 HF 相关住院的复合终点。在 187 名患者中(71.4±11.3 岁,66.8%为男性)共纳入了 233 例 HF 失代偿的疑似病例。LUS1 时的平均 B 线(LUS1)为 17.6±11.2,与 HF 失代偿和无 HF 失代偿的病例相比,分别为 3.7±4.5(P<0.001)。全心 HF 失代偿时 B 线数量最高(20.6±11),其次是左侧(19.7±11.6)和右侧(13.5±9.8)。经过治疗,B 线在平均 24.2±23.7 天(中位数 13.5 天,四分位间距 6-40)内下降至 6.9±6.7(LUS2)(P<0.001 与 LUS1 相比)。B 线在 30 天时与复合终点显著相关(风险比 [HR] 1.04 [95%置信区间 1.01-1.07],P=0.02),但在 60 天(P=0.22)和 180 天(P=0.54)时不相关。多变量分析显示,B 线数量仍然是 30 天时复合终点的独立预测因子[HR 1.04(1.01-1.07),P=0.014],每增加一条 B 线,风险增加 4%。B 线与 CA125 显著相关(R=0.30,P=0.001)。
肺部超声支持慢性 HF 门诊患者充血和去充血的诊断,并识别出短期发生事件风险较高的患者。